Clarus Therapeutics Holdings Inc (CRXTQ)

[ZipCash]

#CRXT @0.46 Rated a buy with $9.00 price target $$$$

Needham Thinks Clarus Therapeutics Holdings’ Stock is Going to Recover
May 17 2022 - 06:16AM
TipRanks
Alert


Needham analyst Serge Belanger maintained a Buy rating on Clarus Therapeutics Holdings (CRXT – Research Report) today and set a price target of $3.00. The company's shares closed last Monday at $0.54, close to its 52-week low of $0.42. According to TipRanks.com, Belanger is a 2-star analyst with an average return of -0.3% and a 40.8% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, Collegium Pharmaceutical, and KalVista Pharmaceuticals. Clarus Therapeutics Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $3.00. See the top stocks recommended by analysts >> The company has a one-year high of $9.
https://www.tipranks.com/news/blurbs/needham-thinks-clarus-therapeutics-holdings-stock-is-going-to-recover-2?utm_source=advfn.com&utm_medium=referral